Qualys (NASDAQ: QLYS) insider schedules 1,801-share Rule 144 stock sale

Rhea-AI Filing Summary

Qualys insider sale planned under Rule 144. A holder associated with Qualys plans to sell 1,801 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $242,360.57, on or about 01/20/2026 on the NASDAQ exchange. The shares to be sold were acquired from the issuer on 11/01/2022 via RSUs/PSUs.

The notice also lists prior sales under a 10b5-1 sales plan for Bruce Posey in the past three months, including 1,077 shares sold on 12/22/2025 for gross proceeds of $153,426.81, 1,000 shares sold on 12/04/2025 for $150,000.00, and 3,077 shares sold on 12/03/2025 for $449,218.56.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1801	242360.57	35858308	01/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/01/2022	RSUs/PSUs	Issuer			1801	11/01/2022	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for BRUCE POSEY 919 E. Hillsdale Boulevard, 4th Floor Foster City CA 94404	Common	12/22/2025	1077	153426.81
10b5-1 Sales Plan for BRUCE POSEY 919 E. Hillsdale Boulevard, 4th Floor Foster City CA 94404	Common	12/04/2025	1000	150000.00
10b5-1 Sales Plan for BRUCE POSEY 919 E. Hillsdale Boulevard, 4th Floor Foster City CA 94404	Common	12/03/2025	3077	449218.56

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Qualys (QLYS) Form 144 filing disclose?

The Form 144 filing discloses a planned sale of 1,801 shares of Qualys common stock under Rule 144, with an aggregate market value of $242,360.57, to be executed on or about 01/20/2026 on the NASDAQ.

How were the Qualys (QLYS) shares being sold acquired?

The 1,801 Qualys common shares covered by this notice were acquired from the issuer on 11/01/2022 through RSUs/PSUs, with the amount of securities acquired shown as 1,801.

Which broker is handling the planned Qualys (QLYS) Rule 144 sale?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, and the securities are listed as trading on NASDAQ.

What recent Qualys (QLYS) insider sales are reported in the past 3 months?

The filing lists sales under a 10b5-1 Sales Plan for Bruce Posey: 1,077 common shares on 12/22/2025 for $153,426.81, 1,000 shares on 12/04/2025 for $150,000.00, and 3,077 shares on 12/03/2025 for $449,218.56.

What is the total number of Qualys (QLYS) shares outstanding referenced in this Form 144?

The Form 144 table notes that the number of Qualys common shares outstanding is 35,858,308 at the time referenced, as context for the 1,801 shares covered by the planned sale.

What representation does the selling person make in the Qualys (QLYS) Form 144?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, and if relying on a Rule 10b5-1 plan, they make this representation as of the plan adoption or instruction date.